MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

K134

CAS No. : 189362-06-9

MCE 站：K134

产品活性：K134 是一种磷酸二酯酶 3 (PDE3) 抑制剂。抑制 PDE3A，PDE3B，PDE5, PDE2，PDE4 和 IC₅₀ 分别为0.1，0.28，12.1，>300 和 >300 μM。

研究领域：Metabolic Enzyme/Protease

作用靶点：Phosphodiesterase (PDE)

In Vitro: K134 (K-134) inhibits rat platelet aggregation induced by collagen and ADP in a dose-dependent manner in vitro. The half-maximal (50%) inhibitory concentration (IC₅₀) values of K134 are 2.5 ?M and 3.2 ?M, respectively. In vitro experiments, K134 also inhibits mouse platelet aggregation induced by collagen and ADP in a dose-dependent manner, and the IC₅₀s are 5.5 ?M and 6.7 ?M, respectively.

In Vivo: K134 (K-134) significantly prolongs middle cerebral artery (MCA) occlusion time at doses >10 mg/kg, and reduces cerebral infarct size at 30 mg/kg in the stroke model (n?=?12, 87.5±5.6 vs. 126.8±7.5 mm³, P<0.01), indicating its potent antithrombotic effect. The overall bleeding risk of K134 is assessed in general in mice. Single oral administration of K134 does not prolong bleeding time at a dose of 30 mg/kg compared to control (106±5 vs. 110±5 s, not significant). Moreover, a sufficiently high enough plasma concentration of K134 (13.6±2.3 ?M) is detected to inhibit platelet aggregation at 10 min after single administration in mice at a dose of 30 mg/kg, which is the same time point as the above test of bleeding time. Next, the effects of PDE3 inhibitors on thrombus formation are also investigated in an arteriovenous shunt model in rats. K134 significantly reduces the incidence of occlusive shunt thrombi at doses above 10 mg/kg (half-maximal effective dose: ED₅₀=11 mg/kg). The plasma concentration of K134 is 0.43±0.08 ?M (C_max) at a dose of 10 mg/kg.

相关产品：IBMX  |  Bucladesine sodium  |  Rolipram  |  Sildenafil  |  Theophylline  |  Icariin  |  Roflumilast  |  Tadalafil  |  PF-04957325  |  Milri  |  Dipyridamole  |  Pentoxifylline  |  Cilostazol  |  Ibudilast  |  Butein  |  Cilomilast  |  Cilostamide  |  EHNA hydrochloride  |  Zardaverine  |  Vardenafil hydrochloride  |  Vinpocetine  |  W-7 hydrochloride  |  BRL-50481  |  HA130  |  Aminophylline  |  Pimobendan  |  Anagrelide hydrochloride  |  Bay 60-7550

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。